These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Adoptive cell therapy using tumor-infiltrating lymphocytes for melanoma refractory to immune-checkpoint inhibitors. Hirai I; Funakoshi T; Kamijuku H; Fukuda K; Mori M; Sakurai M; Koda Y; Kato J; Mori T; Watanabe N; Noji S; Yaguchi T; Iwata T; Ohta S; Fujita T; Tanosaki R; Handa M; Okamoto S; Amagai M; Kawakami Y Cancer Sci; 2021 Aug; 112(8):3163-3172. PubMed ID: 34101300 [TBL] [Abstract][Full Text] [Related]
4. Adoptive transfer of tumor-infiltrating lymphocytes in melanoma: a viable treatment option. Rohaan MW; van den Berg JH; Kvistborg P; Haanen JBAG J Immunother Cancer; 2018 Oct; 6(1):102. PubMed ID: 30285902 [TBL] [Abstract][Full Text] [Related]
5. Adoptive T-cell therapy using autologous tumor-infiltrating lymphocytes for metastatic melanoma: current status and future outlook. Wu R; Forget MA; Chacon J; Bernatchez C; Haymaker C; Chen JQ; Hwu P; Radvanyi LG Cancer J; 2012; 18(2):160-75. PubMed ID: 22453018 [TBL] [Abstract][Full Text] [Related]
6. Achievements and challenges of adoptive T cell therapy with tumor-infiltrating or blood-derived lymphocytes for metastatic melanoma: what is needed to achieve standard of care? Svane IM; Verdegaal EM Cancer Immunol Immunother; 2014 Oct; 63(10):1081-91. PubMed ID: 25099366 [TBL] [Abstract][Full Text] [Related]
7. Impact of Prior Treatment on the Efficacy of Adoptive Transfer of Tumor-Infiltrating Lymphocytes in Patients with Metastatic Melanoma. Seitter SJ; Sherry RM; Yang JC; Robbins PF; Shindorf ML; Copeland AR; McGowan CT; Epstein M; Shelton TE; Langhan MM; Franco Z; Danforth DN; White DE; Rosenberg SA; Goff SL Clin Cancer Res; 2021 Oct; 27(19):5289-5298. PubMed ID: 34413159 [TBL] [Abstract][Full Text] [Related]
8. Focus on adoptive T cell transfer trials in melanoma. Hershkovitz L; Schachter J; Treves AJ; Besser MJ Clin Dev Immunol; 2010; 2010():260267. PubMed ID: 21234353 [TBL] [Abstract][Full Text] [Related]